SEC Form 4 · accession 0001144204-18-052407
INTERCEPT PHARMACEUTICALS, INC. · ICPT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Lisa Bright
Officer — President, International
Period of report
Nov 24, 2017
Accepted (ET)
Oct 3, 2018 · 7:02 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001270073
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1,F3 | Nov 24, 2017 | F | 247 | $63.20 | D | 26,535 | D | |
| Common StockF1,F3 | Dec 18, 2017 | F | 414 | $62.08 | D | 26,535 | D | |
| Common StockF1,F3 | Jan 1, 2018 | F | 935 | $58.42 | D | 26,535 | D | |
| Common StockF1,F3 | Jan 8, 2018 | F | 414 | $53.66 | D | 26,535 | D | |
| Common StockF1,F3 | Feb 24, 2018 | F | 247 | $62.04 | D | 26,535 | D | |
| Common StockF1,F3 | Apr 1, 2018 | F | 522 | $61.52 | D | 26,535 | D | |
| Common StockF1,F3 | May 24, 2018 | F | 247 | $69.76 | D | 26,535 | D | |
| Common StockF2,F3 | May 31, 2018 | A | 879 | $0.00 | A | 26,535 | D | |
| Common StockF1,F3 | May 31, 2018 | F | 414 | $70.21 | D | 26,535 | D | |
| Common StockF1,F3 | Jul 1, 2018 | F | 521 | $83.91 | D | 26,535 | D | |
| Common StockF1,F3 | Aug 24, 2018 | F | 247 | $108.45 | D | 26,535 | D | |
| Common StockF1,F3 | Oct 1, 2018 | F | 521 | $126.46 | D | 26,535 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Represents shares of common stock withheld to satisfy taxes associated with the vesting of restricted stock.
- F2Represents shares of restricted stock that vested upon the achievement of certain performance milestones.
- F3In each case, the amount of securities beneficially owned following the reported transactions is provided as of the date of this Form 4.